DSS
Imagetech thrives on research services
DSS Imagetech offers
latest technologies in microscopy, life sciences research, clinical
diagnostics, imaging, genomics, proteomics and molecular diagnostics
thus aiming to be a total solution provider.
DSS Imagetech is a major solution provider in
the Indian biosuppliers market. It provides cutting-edge technology
solutions to researchers and clinicians working in areas like genetics,
drug discovery, and biotechnology. Its range of products and
application areas include microscopy, image analysis software systems,
genetic workstation, ICSI workstations, DNA probes, and microarray
readers. The company recorded Rs 78.61 crore in revenues in fiscal
2008-09, compared to 68.04 crore in fiscal 2007-08.
DSS has made a constant endeavor to provide cutting-edge technology
solutions to researchers and clinicians in various fields of life
sciences. The product basket extends beyond just instruments to
consumables like antibodies for pathology applications, molecular
biology reagents as well as DNA probes for FISH in prenatal and cancer
genetics. The company has also set up a training laboratory and
conducts workshops for immunohistochemistry as well as FISH for cancer
genetics. The company has long standing international alliances with
Olympus, Applied Imaging, Media Cybernetics, Genomic Solutions,
Illumina, Ultralum, Abott Vysis and an existing customer base of over
4,000 research and clinical institutes in areas such as research and
clinical pathology, molecular biology, IVF-ICSI (in-vitro
fertilization), genetics, telepathology and teleradiology.
DSS provides solutions for a vast number of applications in the field
of genomics including cell based assays (for cell growth and cell
dispensing), gene discovery, gene ID, gene characterization,
differential display, gene expression analysis, arraying,
hybridization, drug discovery, compound library management, assay
assembly, SNP setup, genotyping, PCR, DNA/RNA synthesis,
oligonucleotide synthesis, sequencing, DNA shearing, clone production
and low volume sequencing.
The fiscal 2007-08 saw consumables and reagents as being the biggest
growth driver for the company with Dako (pathology) Takara Clonetech
(molecular biology reagents) and Abbott Molecular showing double digit
growth. Viral load testing for HIV and HER2NO from Abbott for detecting
breast cancer were also revenue grossing technologies. The company has
installed quite a few microarrays in the last few years and has been
training people in IHC and FISH technologies. The company tied up with
Carestream Health that acquired Kodak imaging products and also
strengthened its relationship with Beckman Coulter.